title: The "Next Big Thing" in Treatment for Relapsed or Refractory Multiple Myeloma May Be Held Back by Design-Between the Lines.
authors.affiliation: Department of Psychology, University of Cambridge, Cambridge, England.
authors.forename: Kai
authors.initials: K
authors.lastname: Ruggeri
authors.affiliation: Department of Psychology, University of Cambridge, Cambridge, England.
authors.forename: Áine
authors.initials: Á
authors.lastname: Maguire
authors.affiliation: Leeds University & Leeds Teaching Hospital, St James Hospital, Leeds, England.
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome